Trials / Completed
CompletedNCT04683614
Intraoperative Norepinephrine Versus Fresh Frozen Plasma in Patients Undergoing HIPEC to Reduce Renal Insult
Intraoperative Norepinephrine Versus Fresh Frozen Plasma in Patients Undergoing HIPEC to
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- National Cancer Institute, Egypt · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
comparing the effect of low dose norepinephrine infusion versus fresh frozen plasma in patients undergoing HIPEC to reduce renal insult
Detailed description
To compare the efficacy of maintaining intraoperative hemodynamic stability through infusing low dose norepinephrine versus fresh frozen plasma in patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy in cancer patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Norepinephrine | 5 mic/kg/hr norepinephrine |
| BIOLOGICAL | Fresh frozen plasma | early administration of fresh frozen plasma |
Timeline
- Start date
- 2020-10-20
- Primary completion
- 2022-05-20
- Completion
- 2022-05-28
- First posted
- 2020-12-24
- Last updated
- 2022-06-21
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04683614. Inclusion in this directory is not an endorsement.